方法：选择2010-01/2012-12于我院就诊的视网膜静脉阻塞伴黄斑水肿的患者56例为研究对象。所有患者均接受卵磷脂络合碘片和复方血栓通胶囊传统常规治疗，中央静脉阻塞(central retinal vein occlusion，CRVO)、半侧中央静脉阻塞(hemi-central retinal vein occlusion，hemi-CRVO)和分支静脉阻塞(branch retinal vein occlusion，BRVO)分别进行曲安奈德联合激光治疗，随访时间至少6mo。

结果：治疗1，3，6mo后，患者黄斑中心凹厚度均有明显降低(P<0.05)。治疗后，随访6～12mo发现，CRVO、hemi-CRVO和BRVO患者的总有效率为83%～95%，并且患者未出现明显的不良反应。

结论：在传统治疗基础上给予玻璃体腔注射曲安奈德联合眼底激光可有效治疗视网膜静脉阻塞，值得临床推广。

METHODS: Fifty-six patients of retinal obstruction with macular edema were accepted from January 2010 to December 2012 in our hospital. All patients received iodized lecithin and Xueshuantong. And, patients with central retinal vein occlusion(CRVO), hemi-central retinal vein occlusion(hemi-CRVO)and branch retinal vein occlusion(BRVO)treated by TA combined with laser photocoagulation, respectively. Follow-up period was of at least 6mo

RESULTS: After the treatment of 1,3 and 6mo, the central foveal thickness was reduced significantly(P<0.05). After followed up 6-12mo, the total effective rate of CRVO, Hemi-CRVO and BRVO patients was 83%～95% and all the patients had no significant adverse reactions.

CONCLUSION: Basing on the traditional treatment, TA combined with laser photocoagulation is more effective in the treatment of retinal vein occlusion and is worthy of clinical usage.